The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cardiovascular Pharmacology and Therapeutics"
DOI: 10.1177/10742484211058681
Abstract: Heart failure (HF) is one of the leading causes of morbidity and mortality worldwide. Sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor, has been approved for the treatment of HF. At present, there have been few systematic and… read more here.
Keywords: safety; sacubitril valsartan; heart failure; efficacy safety ... See more keywords
Efficacy and safety of sacubitril/valsartan on heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.897423
Abstract: Aims The efficacy and safety of sacubitril/valsartan for patients with heart failure with preserved ejection fraction (HFpEF) are controversial. Hence, the primary objective of the study was to evaluate the efficacy and safety of sacubitril/valsartan… read more here.
Keywords: heart failure; sacubitril valsartan; sacubitril; efficacy safety ... See more keywords